N-methylidene-N'-[(E)-3,3,3-trifluoro-2-methylprop-1-enyl]piperazine-1-carboximidamide
C10H15F3N4 — CID 174328324
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-methylidene-N'-[(E)-3,3,3-trifluoro-2-methylprop-1-enyl]piperazine-1-carboximidamide
N-methylidene-N'-[(E)-3,3,3-trifluoro-2-methylprop-1-enyl]piperazine-1-carboximidamide (PubChem CID 174328324) has the molecular formula C10H15F3N4 and a molecular weight of 248.25 g/mol. Its IUPAC name is N-methylidene-N'-[(E)-3,3,3-trifluoro-2-methylprop-1-enyl]piperazine-1-carboximidamide.
Molecular Properties
| Compound Name | N-methylidene-N'-[(E)-3,3,3-trifluoro-2-methylprop-1-enyl]piperazine-1-carboximidamide |
|---|---|
| PubChem CID | 174328324 |
| Molecular Formula | C10H15F3N4 |
| Molecular Weight | 248.25 g/mol |
| Exact Mass | 248.12 |
| IUPAC Name | N-methylidene-N'-[(E)-3,3,3-trifluoro-2-methylprop-1-enyl]piperazine-1-carboximidamide |
| SMILES | C=N/C(=N\C=C(/C)C(F)(F)F)N1CCNCC1 |
| InChI | InChI=1S/C10H15F3N4/c1-8(10(11,12)13)7-16-9(14-2)17-5-3-15-4-6-17/h7,15H,2-6H2,1H3/b8-7+,16-9+ |
| InChIKey | XUDMRKSXMDYAAH-BVQNTDGTSA-N |
| XLogP | 1.41 |
| TPSA | 39.99 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 17 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 248.25 |
| LogP ≤ 5 | 1.41 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174328324 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.